Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Parsons
PSN
$5.1B
| $937K | ﹤0.01% |
20,937
+4,023
| +24% | +$177K |
|
|
ATSG
502
DELISTED
Air Transport Services Group
ATSG
| $936K | ﹤0.01% |
44,955
+9,599
| +27% | +$232K |
|
503
Super Micro Computer
SMCI
$19.6B
| $926K | ﹤0.01% |
+86,950
| New | +$785K |
|
504
Atkore
ATKR
$3.16B
| $907K | ﹤0.01% |
6,454
-1,459
| -18% | -$198K |
|
|
SWAV
505
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $904K | ﹤0.01% |
4,168
-76,924
| -95% | -$15M |
|
506
ACI Worldwide
ACIW
$5.88B
| $903K | ﹤0.01% |
33,452
-1,405
| -4% | -$37.2K |
|
507
Pacific Biosciences
PACB
$404M
| $892K | ﹤0.01% |
76,988
-1,700
| -2% | -$16.9K |
|
508
Modine Manufacturing
MOD
$10.3B
| $886K | ﹤0.01% |
+38,450
| New | +$887K |
|
509
Green Brick Partners
GRBK
$3.15B
| $864K | ﹤0.01% |
24,631
-9,605
| -28% | -$297K |
|
510
Electronic Arts
EA
$52.9B
| $847K | ﹤0.01% |
7,030
-4,356
| -38% | -$512K |
|
511
Allegro MicroSystems
ALGM
$7.79B
| $844K | ﹤0.01% |
+17,589
| New | +$716K |
|
512
EXL Service
EXLS
$5.11B
| $829K | ﹤0.01% |
25,615
-1,070
| -4% | -$35.5K |
|
513
Avista
AVA
$3.25B
| $825K | ﹤0.01% |
+19,440
| New | +$805K |
|
|
WIRE
514
DELISTED
Encore Wire Corp
WIRE
| $798K | ﹤0.01% |
4,306
-1,877
| -30% | -$320K |
|
515
Mettler-Toledo International
MTD
$28.5B
| $791K | ﹤0.01% |
517
+346
| +202% | +$520K |
|
516
Brady Corp
BRC
$4.62B
| $780K | ﹤0.01% |
+14,519
| New | +$760K |
|
517
Haemonetics
HAE
$3.8B
| $779K | ﹤0.01% |
9,419
-391
| -4% | -$31.7K |
|
518
O-I Glass
OI
$1.15B
| $776K | ﹤0.01% |
34,188
-34,923
| -51% | -$733K |
|
519
Merit Medical Systems
MMSI
$5.21B
| $769K | ﹤0.01% |
+10,397
| New | +$729K |
|
|
RDFN
520
DELISTED
Redfin
RDFN
| $768K | ﹤0.01% |
84,780
-81,927
| -49% | -$611K |
|
521
Gray Television
GTN
$447M
| $765K | ﹤0.01% |
87,703
+8,832
| +11% | +$98.5K |
|
522
Kraft Heinz
KHC
$30.5B
| $763K | ﹤0.01% |
19,724
| – | – |
|
523
Rush Street Interactive
RSI
$2.67B
| $760K | ﹤0.01% |
244,373
-801,521
| -77% | -$3.08M |
|
524
Terex
TEX
$7.55B
| $756K | ﹤0.01% |
+15,631
| New | +$799K |
|
525
NETSCOUT
NTCT
$2.98B
| $755K | ﹤0.01% |
26,340
+888
| +3% | +$26.6K |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.